Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 4
1998 5
1999 1
2000 3
2002 1
2003 1
2004 2
2005 3
2006 1
2007 1
2009 1
2010 3
2011 3
2012 1
2015 3
2016 6
2017 2
2018 2
2019 4
2020 4
2021 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Cremolini C, Loupakis F, Antoniotti C, Lupi C, Sensi E, Lonardi S, Mezi S, Tomasello G, Ronzoni M, Zaniboni A, Tonini G, Carlomagno C, Allegrini G, Chiara S, D'Amico M, Granetto C, Cazzaniga M, Boni L, Fontanini G, Falcone A. Cremolini C, et al. Among authors: granetto c. Lancet Oncol. 2015 Oct;16(13):1306-15. doi: 10.1016/S1470-2045(15)00122-9. Epub 2015 Aug 31. Lancet Oncol. 2015. PMID: 26338525 Clinical Trial.
Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation.
Lonardi S, Rasola C, Lobefaro R, Rossini D, Formica V, Scartozzi M, Frassineti GL, Boscolo G, Cinieri S, Di Donato S, Pella N, Bergamo F, Raimondi A, Arnoldi E, Antonuzzo L, Granetto C, Zustovich F, Ronzoni M, Leo S, Morano F, Loupakis F, Buggin F, Zagonel V, Fassan M, Cremolini C, Boni L, Pietrantonio F; GONO Foundation Investigators. Lonardi S, et al. Among authors: granetto c. J Clin Oncol. 2023 Dec 1;41(34):5263-5273. doi: 10.1200/JCO.23.00506. Epub 2023 Aug 3. J Clin Oncol. 2023. PMID: 37535876 Clinical Trial.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Among authors: granetto c. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G; Gruppo Oncologico Nord Ovest. Falcone A, et al. Among authors: granetto c. J Clin Oncol. 2007 May 1;25(13):1670-6. doi: 10.1200/JCO.2006.09.0928. J Clin Oncol. 2007. PMID: 17470860 Clinical Trial.
Prostate cancer.
Repetto L, Granetto C, Hall RR. Repetto L, et al. Among authors: granetto c. Crit Rev Oncol Hematol. 1998 Feb;27(2):145-6. doi: 10.1016/s1040-8428(97)10024-5. Crit Rev Oncol Hematol. 1998. PMID: 9571318 Review. No abstract available.
Lung cancer.
Repetto L, Granetto C, Venturino A, de Pas T, Giacone G. Repetto L, et al. Among authors: granetto c. Crit Rev Oncol Hematol. 1998 Feb;27(2):133-4. doi: 10.1016/s1040-8428(97)10020-8. Crit Rev Oncol Hematol. 1998. PMID: 9571315 Review. No abstract available.
Gynaecologic cancers.
Repetto L, Granetto C, Aapro M, Pecorelli S. Repetto L, et al. Among authors: granetto c. Crit Rev Oncol Hematol. 1998 Feb;27(2):147-50. doi: 10.1016/s1040-8428(97)10025-7. Crit Rev Oncol Hematol. 1998. PMID: 9571319 Review. No abstract available.
Heterogeneity of colon cancer: from bench to bedside.
Merlano MC, Granetto C, Fea E, Ricci V, Garrone O. Merlano MC, et al. Among authors: granetto c. ESMO Open. 2017 Aug 22;2(3):e000218. doi: 10.1136/esmoopen-2017-000218. eCollection 2017. ESMO Open. 2017. PMID: 29209524 Free PMC article. Review.
Screening and chemoprevention.
Repetto L, Granetto C, Venturino A, Aapro M. Repetto L, et al. Among authors: granetto c. Crit Rev Oncol Hematol. 1998 Feb;27(2):111-5. doi: 10.1016/s1040-8428(97)10013-0. Crit Rev Oncol Hematol. 1998. PMID: 9571308 Review. No abstract available.
Home care in the older person.
Repetto L, Granetto C, Venturino A. Repetto L, et al. Among authors: granetto c. Clin Geriatr Med. 1997 May;13(2):403-13. Clin Geriatr Med. 1997. PMID: 9115458 Review.
55 results